Seeing the Unknown with DeepView®
We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care with our proprietary AI platform and DeepView® product.
Where Science + Technology Meet
Technology that provides an immediate wound healing assessment to clinicians with physiological information that is not visible to the human eye, using multi-spectral imaging and Artificial Intelligence.
Funding and technical support for development of DeepView® Wound Imaging System is provided by the Biomedical Advanced Research and Development Authority (BARDA), under the Assistant Secretary for Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), under ongoing USG Contract No. 75A50119C00033.
For more information about BARDA, refer to www.phe.gov/about/BARDA.
In 2018, the FDA designated DeepView® with Breakthrough Device status.
Connect with Us
2515 McKinney Avenue, Ste. 1000
Dallas, Texas 75201